ALI-JACKSON KAMIL sold 19.8% of their position (2.50K shares) of RIGEL PHARMACEUTICALS INC on the open market
Open‑market sale worth $87.5K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/24/2026ACC: 0000905148-26-003076
Director
Since Dec 2021
-2.50K
Net shares
Net seller
$87.5K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
2.50K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2.50K
Price / share
$35.00
Trade value
$87.50K
% of position
19.8%
6/22/2026
12.63K→10.13K
Total
Net shares
−2.50K
Net value
-$87.50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/22/2026 | S · Sale | −2.50K | $35.00 | $87.50K | 19.8% | 12.63K | 10.13K |
| Total | −2.50K | -$87.50K | ||||||
Derivative Transactions0
No derivative transactions reported